For subscribers
Ozempic is transforming the health of Denmark’s economy
The success of Novo Nordisk shows the outsized effect a single company can have on a nation.
Sign up now: Get ST's newsletters delivered to your inbox
National dependence on a single commodity, of course, can have serious downsides.
PHOTO: REUTERS
Tyler Cowen
Follow topic:
From both a biomedical and economic point of view, the success of the new class of weight-loss drugs is something to behold. Not only are they a remarkable scientific achievement, but also – in the case of Ozempic and Wegovy, both made by Novo Nordisk – they are a huge boon to the Danish economy.
The Danish pharmaceutical industry kept Denmark from falling into a recession in 2023.
